Evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: A prospective randomized study

BACKGROUND: Mature oocytes are prerequisite for achieving the process of in vitro fertilization. Human chorionic gonadotropin (hCG) is the standard trigger used for stimulating ovulation but is associated with ovarian hyperstimulation syndrome (OHSS). Gonadotropin-releasing hormone agonist trigger a...

Full description

Bibliographic Details
Main Authors: Nalini Mahajan, Shilpa Sharma, Puneet Rana Arora, Shalu Gupta, Kumkum Rani, Padmaja Naidu
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Journal of Human Reproductive Sciences
Subjects:
Online Access:http://www.jhrsonline.org/article.asp?issn=0974-1208;year=2016;volume=9;issue=2;spage=101;epage=106;aulast=Mahajan
id doaj-12e77d4b35914e20b107ad405250da40
record_format Article
spelling doaj-12e77d4b35914e20b107ad405250da402020-11-25T01:30:18ZengWolters Kluwer Medknow PublicationsJournal of Human Reproductive Sciences0974-12081998-47662016-01-019210110610.4103/0974-1208.183506Evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: A prospective randomized studyNalini MahajanShilpa SharmaPuneet Rana AroraShalu GuptaKumkum RaniPadmaja NaiduBACKGROUND: Mature oocytes are prerequisite for achieving the process of in vitro fertilization. Human chorionic gonadotropin (hCG) is the standard trigger used for stimulating ovulation but is associated with ovarian hyperstimulation syndrome (OHSS). Gonadotropin-releasing hormone agonist trigger achieves oocyte maturation and lowers the incidence of OHSS, but it has limitations of higher pregnancy loss rate and miscarriage rates. Coadministration of both hormones is found to improve the pregnancy rates and the number of mature oocytes retrieved. We aimed to assess if the dual trigger is better than the conventional hCG in triggering oocyte maturation. METHODOLOGY: The study included 76 female patients aged 24–43 years who were randomly divided into two groups with 38 patients in each arm. The study included patients with antimullerian hormone (AMH) <4 ng/ml, antral follicle counts (AFCs)/ovary <12. The study excluded high responders-AMH >4 ng/ml and AFC/ovary >12 to avoid OHSS risk with hCG trigger. RESULTS: The study showed statistically insignificant differences between dual group versus hCG group in terms of the number of oocytes retrieved (10.0 ± 5.6 vs. 8.7 ± 5.0; P = 0.2816), the number of mature oocytes recovered (8.4 ± 5.0 vs. 7.2 ± 4.0; P = 0.2588), fertilization rate (5.9 ± 4.2 vs. 5.6 ± 3.3; P = 0.7390), and the number of usable embryos on day 3 (4.0 ± 3.0 vs. 4.0 ± 2.4; P = 0.8991). CONCLUSION: The dual trigger is equivalent to hCG in triggering oocyte maturation.http://www.jhrsonline.org/article.asp?issn=0974-1208;year=2016;volume=9;issue=2;spage=101;epage=106;aulast=MahajanDual triggergonadotropin.releasing hormone agonist triggeroocyte maturation
collection DOAJ
language English
format Article
sources DOAJ
author Nalini Mahajan
Shilpa Sharma
Puneet Rana Arora
Shalu Gupta
Kumkum Rani
Padmaja Naidu
spellingShingle Nalini Mahajan
Shilpa Sharma
Puneet Rana Arora
Shalu Gupta
Kumkum Rani
Padmaja Naidu
Evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: A prospective randomized study
Journal of Human Reproductive Sciences
Dual trigger
gonadotropin.releasing hormone agonist trigger
oocyte maturation
author_facet Nalini Mahajan
Shilpa Sharma
Puneet Rana Arora
Shalu Gupta
Kumkum Rani
Padmaja Naidu
author_sort Nalini Mahajan
title Evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: A prospective randomized study
title_short Evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: A prospective randomized study
title_full Evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: A prospective randomized study
title_fullStr Evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: A prospective randomized study
title_full_unstemmed Evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: A prospective randomized study
title_sort evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: a prospective randomized study
publisher Wolters Kluwer Medknow Publications
series Journal of Human Reproductive Sciences
issn 0974-1208
1998-4766
publishDate 2016-01-01
description BACKGROUND: Mature oocytes are prerequisite for achieving the process of in vitro fertilization. Human chorionic gonadotropin (hCG) is the standard trigger used for stimulating ovulation but is associated with ovarian hyperstimulation syndrome (OHSS). Gonadotropin-releasing hormone agonist trigger achieves oocyte maturation and lowers the incidence of OHSS, but it has limitations of higher pregnancy loss rate and miscarriage rates. Coadministration of both hormones is found to improve the pregnancy rates and the number of mature oocytes retrieved. We aimed to assess if the dual trigger is better than the conventional hCG in triggering oocyte maturation. METHODOLOGY: The study included 76 female patients aged 24–43 years who were randomly divided into two groups with 38 patients in each arm. The study included patients with antimullerian hormone (AMH) <4 ng/ml, antral follicle counts (AFCs)/ovary <12. The study excluded high responders-AMH >4 ng/ml and AFC/ovary >12 to avoid OHSS risk with hCG trigger. RESULTS: The study showed statistically insignificant differences between dual group versus hCG group in terms of the number of oocytes retrieved (10.0 ± 5.6 vs. 8.7 ± 5.0; P = 0.2816), the number of mature oocytes recovered (8.4 ± 5.0 vs. 7.2 ± 4.0; P = 0.2588), fertilization rate (5.9 ± 4.2 vs. 5.6 ± 3.3; P = 0.7390), and the number of usable embryos on day 3 (4.0 ± 3.0 vs. 4.0 ± 2.4; P = 0.8991). CONCLUSION: The dual trigger is equivalent to hCG in triggering oocyte maturation.
topic Dual trigger
gonadotropin.releasing hormone agonist trigger
oocyte maturation
url http://www.jhrsonline.org/article.asp?issn=0974-1208;year=2016;volume=9;issue=2;spage=101;epage=106;aulast=Mahajan
work_keys_str_mv AT nalinimahajan evaluationofdualtriggerwithgonadotropinreleasinghormoneagonistandhumanchorionicgonadotropininimprovingoocytematurityratesaprospectiverandomizedstudy
AT shilpasharma evaluationofdualtriggerwithgonadotropinreleasinghormoneagonistandhumanchorionicgonadotropininimprovingoocytematurityratesaprospectiverandomizedstudy
AT puneetranaarora evaluationofdualtriggerwithgonadotropinreleasinghormoneagonistandhumanchorionicgonadotropininimprovingoocytematurityratesaprospectiverandomizedstudy
AT shalugupta evaluationofdualtriggerwithgonadotropinreleasinghormoneagonistandhumanchorionicgonadotropininimprovingoocytematurityratesaprospectiverandomizedstudy
AT kumkumrani evaluationofdualtriggerwithgonadotropinreleasinghormoneagonistandhumanchorionicgonadotropininimprovingoocytematurityratesaprospectiverandomizedstudy
AT padmajanaidu evaluationofdualtriggerwithgonadotropinreleasinghormoneagonistandhumanchorionicgonadotropininimprovingoocytematurityratesaprospectiverandomizedstudy
_version_ 1725092293755535360